Your browser doesn't support javascript.
loading
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
Bines, José; Clark, Emma; Barton, Claire; Restuccia, Eleonora; Procter, Marion; Sonnenblick, Amir; Fumagalli, Debora; Parlier, Damien; Arahmani, Amal; Baselga, José; Viale, Giuseppe; Reaby, Linda L; Frank, Elizabeth; Gelber, Richard D; Piccart, Martine; Jackisch, Christian; Petersen, Jennifer A.
Afiliação
  • Bines J; Department of Medical Oncology, Instituto Nacional de Câncer, Rio de Janeiro, Brazil. jose_bines@yahoo.com.
  • Clark E; Roche Products Limited, Welwyn Garden City, UK.
  • Barton C; Roche Products Limited, Welwyn Garden City, UK.
  • Restuccia E; Barton Oncology Ltd, Croxley Green, Hertfordshire, UK.
  • Procter M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Sonnenblick A; Frontier Science (Scotland) Ltd, Kincraig, UK.
  • Fumagalli D; Breast European Adjuvant Study Team (BrEAST), Brussels, Belgium.
  • Parlier D; Oncology Division, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Arahmani A; Breast International Group (BIG), Brussels, Belgium.
  • Baselga J; Breast European Adjuvant Study Team (BrEAST), Brussels, Belgium.
  • Viale G; Breast International Group (BIG), Brussels, Belgium.
  • Reaby LL; Formerly of Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Frank E; Formerly of AstraZeneca, Gaithersburg, MD, USA.
  • Gelber RD; IEO European Institute of Oncology IRCCS, University of Milan, Milan, Italy.
  • Piccart M; Breast Cancer Trials, Newcastle, NSW, Australia.
  • Jackisch C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Petersen JA; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science & Technology Research Foundation, Inc., Boston, MA, USA.
Br J Cancer ; 125(1): 38-47, 2021 07.
Article em En | MEDLINE | ID: mdl-33828257

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article